EMEA
Mylan operates throughout Europe, the Middle East and Africa (EMEA), with
manufacturing, packaging, distribution and marketing capabilities throughout
the region. These businesses presently hold top-five positions in several
markets, including No. 1 positions in France and Portugal. Mylan also has a
strong presence – and significant opportunities for growth – in Spain, Italy,
Portugal, Belgium, the Netherlands, Scandinavia and Ireland. Mylan EMEA
businesses include those that operate under the "Mylan" name in:
Austria, Belgium, the Czech Republic, Denmark, Finland, France,
Germany, Hungary, Italy, the Netherlands, Norway, Poland, Portugal,
Scandinavia, Slovakia, Slovenia, Spain, Sweden, Switzerland and South Africa.
Our other EMEA businesses include:
Matrix Laboratories also owns and operates Docpharma,
a distributor of generic pharmaceuticals in Belgium, the Netherlands and
Luxembourg.